Elevance Health earnings beat by $0.03, revenue fell short of estimates By Investing.com

  • Post category:Stock Markets
  • Reading time:2 mins read

Elevance Health earnings beat by $0.03, revenue fell short of estimates © Reuters. Elevance Health earnings beat by $0.03, revenue fell short of estimates   ELV +0.12% Add to/Remove from a Portfolio Add to Watchlist Add Position

Position added successfully to:

Please name your holdings portfolio Type: BUY SELL Date:   Amount: Price Point Value: Leverage: 1:1 1:10 1:25 1:50 1:100 1:200 1:400 1:500 1:1000 Commission:   Create New Watchlist Create Create a new holdings portfolio Add Create + Add another position Close

Investing.com – Elevance Health (NYSE: ELV) reported fourth quarter EPS of $5.23, $0.03 better than the analyst estimate of $5.20. Revenue for the quarter came in at $39.67B versus the consensus estimate of $39.72B.

Guidance

Elevance Health sees FY 2023 EPS of $32.60 versus the analyst consensus of $32.69.

Elevance Health sees FY 2023 revenue of $164.00B versus the analyst consensus of $163.90B.

Elevance Health’s stock price closed at $478.52. It is down -11.98% in the last 3 months and up 11.69% in the last 12 months.

Elevance Health saw 3 positive EPS revisions and 16 negative EPS revisions in the last 90 days. See Elevance Health’s stock price’s past reactions to earnings here.

According to InvestingPro, Elevance Health’s Financial Health score is “great performance”.

Check out Elevance Health’s recent earnings performance, and Elevance Health’s financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar

Elevance Health earnings beat by $0.03, revenue fell short of estimates  

Leave a Reply